Abstract
Objective
The objective of this study was to evaluate the incidence of incidental parotid masses with conventional whole-body 18F-deoxyglucose (FDG) PET/CT and assess the ability of PET/CT to characterize these unexpected parotid lesions.
Methods
Fifty eight incidental findings of parotid masses with routine FDG PET/CT whole-body scan were reviewed in this retrospective analysis, which were selected from the patients without any known or suspected parotid disease in our PET center, from June 2005 to May 2009. 51 cases were operated or underwent a biopsy after a short-term PET/CT study; the remaining 7 cases had a follow-up. Parotid mass that showed both noncontrast CT (irregular shape and blurry border) and PET malignant features (high FDG uptake, SUVmax > 3.0) was considered as positive for malignancy. Correlation of FDG PET/CT with histology or follow-up outcome was performed.
Results
Fifty eight unexpected findings of parotid masses accounted for 0.3% of the total cases in 4 years, including 11 (19.0%) malignant tumors and 47 (81.0%) benign lesions. 13 lesions manifested single nodule with malignant CT features and intense FDG activity, of which 6 were proved to be malignant; thus, sensitivity and positive predictive values were 54.5% (6 of 11) and 46.2% (6 of 13), respectively. 45 lesions showed either single nodule with benign CT features, or a low FDG uptake (SUVmax ≤ 3.0), of which 40 were true negatives; therefore, specificity and negative predictive values were 85.1% (40 of 47) and 88.9% (40 of 45), respectively. All parotid masses except 9 benign and 1 malignant showed a high FDG uptake. Compared with SUV only, combined interpretation of PET and CT results displayed a lower sensitivity (90.9–54.5%), but a higher specificity (19.1–85.1%) and a higher overall accuracy.
Conclusions
Whole-body FDG-PET/CT at the time of surveying the entire body condition is helpful for detecting the asymptomatic parotid masses. Combined noncontrast CT is an essential evidence for improving the diagnostic accuracy of FDG-PET/CT for parotid masses.
Similar content being viewed by others
References
Lee YYP, Wong KT, King AD, Ahuja AT. Imaging of salivary gland tumours. Eur J Radiol. 2008;66:419–36.
Mehta A, Bansal SC. Diagnosis and management of cancer. Jaypee Brothers Medical Publishers (P) Ltd.; 2004. p. 232–52.
Lin CC, Tsai MH, Huang CC, Hua CH, Tseng HC, Huang ST. Parotid tumors: a 10-year experience. Am J Otolaryngol. 2008;29:94–100.
Burgess AN, Serpell GW. Parotidectomy: preoperative investigations and outcomes in a single surgeon practice. ANZ J Surg. 2008;78:791–3.
Subhashraj K. Salivary gland tumors: a single institution experience in India. Br J Oral Maxillofac Surg. 2008;46:635–8.
Even-Sapir E, Lerman H, Gutman M, Lievshitz G, Zuriel L, Polliack A, et al. The presentation of malignant tumours and pre-malignant lesions incidentally found on PET-CT. Eur J Nucl Med Mol Imaging. 2006;33:541–52.
Ishimori T, Patel PV, Wahl RL. Detection of unexpected additional primary malignancies with PET/CT. J Nucl Med. 2005;46:752–7.
Adriaensen M, Schijf L, Haas M, Huijbregts J, Baarslag HJ, Staaks G, et al. Six synchronous primary neoplasms detected by FDG-PET/CT. Eur J Nucl Med Mol Imaging. 2008;35:1931.
Choi JY, Lee KS, Kwon OJ, Shim YM, Baek CH, Park K, et al. Improved detection of second primary cancer using integrated [18F] fluorodeoxyglucose positron emission tomography and computed tomography for initial tumor staging. J Clin Oncol. 2005;23:7654–9.
De Wever W, Vankan Y, Stroobants S, Verschakelen J. Detection of extrapulmonary lesions with integrated PET/CT in the staging of lung cancer. Eur Respir J. 2007;29:995–1002.
Branstetter BF, Blodgett TM, Zimmer LA, Synderman CH, Johnson JT, Raman S, et al. Head and neck malignancy: is PET/CT more accurate than PET or CT alone? Radiology. 2005;235:580–6.
Bar-Shalom R, Yefremov N, Guralnik L, Gaitini D, Frenkei A, Kuten A, et al. Clinical performance of PET/CT in evaluation of cancer: additional value for diagnostic imaging and patient management. J Nucl Med. 2003;44:1200–9.
Uchida Y, Minoshima S, Kawata T, Motoori K, Nakano K, Kazama T, et al. Diagnostic value of FDG PET and salivary gland scintigraphy for parotid tumors. Clin Nucl Med. 2005;30:170–6.
Okamura T, Kawabe J, Koyama K, Ochi H, Yamada R, Sakamoto H, et al. Fluorine-18 fluorodeoxyglucose positron emission tomography imaging of parotid mass lesions. Acta Otolaryngol Suppl. 1998;538:209–13.
Basu S, Houseni M, Alavi A. Significance of incidental fluorodeoxyglucose uptake in the parotid glands and its impact on patient management. Nucl Med Commun. 2008;29:367–73.
Rumboldt D, Gordon L, Bonsall R, Ackermann S. Imaging in head and neck cancer. Curr Treat Options Oncol. 2006;7:23–34.
Keyes JW, Harkness BA, Greven KM, Williams DW, Watson NE, Frederick-McGuirt W. Salivary gland tumors: pretherapy evaluation with PET. Radiology. 1994;192:99–102.
Shah VN, Branstetter BF. Oncocytoma of the parotid gland: a potential false-positive finding on 18F-FDG PET. Am J Roentgenol. 2007;189:W212–4.
Rubello D, Nanni C, Castellucci P, Rampin L, Farsad M, Franchi R, et al. Does 18F-FDG PET/CT play a role in the differential diagnosis of parotid masses. Panminerva Med. 2005;47:187–9.
Ozawa N, Okamura T, Koyama K, Nakayama K, Kawabe J, Shiomi S, et al. Retrospective review: usefulness of a number of imaging modalities including CT, MRI, technetium-99m pertechnetate scintigraphy, gallium-67 scintigraphy and F-18-FDG PET in the differentiation of benign from malignant parotid masses. Radiat Med. 2006;24:41–9.
Lim CY, Chang HC, Nam KH, Chung WY, Park CS. Preoperative prediction of the location of parotid gland tumors using anatomical landmarks. World J Surg. 2008;32:2200–3.
Author information
Authors and Affiliations
Corresponding author
Additional information
H.-C. Wang and C.-T. Zuo contributed equally to this work.
Rights and permissions
About this article
Cite this article
Wang, HC., Zuo, CT., Hua, FC. et al. Efficacy of conventional whole-body 18F-FDG PET/CT in the incidental findings of parotid masses. Ann Nucl Med 24, 571–577 (2010). https://doi.org/10.1007/s12149-010-0394-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12149-010-0394-6